Back | Next |
home / stock / nktx / nktx message board
Subject | By | Source | When |
---|---|---|---|
znewcar1: NKTX 141% v109M C18.72 f33M H18.95 gapN held yet choppy | znewcar1 | investorshangout | 04/26/2022 1:08:28 AM |
Price target is 109. Wouldnt consider 18 high | rynlrt | investorshub | 04/26/2022 12:07:55 AM |
thats assuming a high price of 18 | TheFinalCD | investorshub | 04/25/2022 8:25:50 PM |
That's only about 10M shares if @ 18.00 | crudeoil24 | investorshub | 04/25/2022 8:21:50 PM |
Turn your monitor upside down! lol | crudeoil24 | investorshub | 04/25/2022 8:10:11 PM |
UP ON OFFERING NEWS | TheFinalCD | investorshub | 04/25/2022 8:09:01 PM |
I see > $NKTX @ 19.84 now. Probably | crudeoil24 | investorshub | 04/25/2022 8:06:59 PM |
$NKTX Nkarta Announces Proposed Public Offering of Common Stock | TheFinalCD | investorshub | 04/25/2022 8:02:18 PM |
znewcar1: oard created in 2020 frow what looks like a BO38 to HH79.16 YL7.55 morning pop over 15 | znewcar1 | investorshangout | 04/25/2022 7:34:48 PM |
Thank you ! I wish Elon Musk buy | crudeoil24 | investorshub | 04/25/2022 7:28:39 PM |
18.94 CONGRAT$ | TheFinalCD | investorshub | 04/25/2022 7:26:48 PM |
PT > 109.00 > Mizuho Maintain Buys On | crudeoil24 | investorshub | 04/25/2022 7:26:07 PM |
$NKTX > PHI SLAMMA JAMA! | crudeoil24 | investorshub | 04/25/2022 7:18:13 PM |
$NKTX > 17.94 | crudeoil24 | investorshub | 04/25/2022 6:57:34 PM |
znewcar1: ML7.55l HOD16.46 a gap fill to 16.35+19.75 | znewcar1 | investorshangout | 04/25/2022 6:49:16 PM |
Another group plans to test an anti-CD70 CAR-NK | jondoeuk | investorshub | 04/25/2022 6:01:10 PM |
More (preclinical data) from the same group | jondoeuk | investorshub | 04/25/2022 5:55:06 PM |
A PhI is planned | jondoeuk | investorshub | 04/25/2022 5:52:04 PM |
MICA and MICB, as well as ULBP 1-6 | jondoeuk | investorshub | 04/25/2022 5:45:19 PM |
Let's go $NKTX ..... | crudeoil24 | investorshub | 04/25/2022 4:04:32 PM |
News, Short Squeeze, Breakout and More Instantly...
Nkarta Inc. Company Name:
NKTX Stock Symbol:
NASDAQ Market:
Dosing of first patient with NKX019 for lupus nephritis using disease-tailored lymphodepletion expected in first half of 2024 Cash balance of $450.0 million on March 31, 2024, including cash, cash equivalents and investments Strong balance sheet, bolstered by recent $240.1 milli...
Thursday, Century Therapeutics (NASDAQ:IPSC) unveiled plans to expand clinical development for its lead program, CNTY-101, a CD19-targeti...